Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05337904 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia

Study acronym: DBS-R
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 29, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 1, 2023 to Mar 1, 2026v2 Show 5 more changesShow less
    • Start date: Jan 1, 2021 to Sep 1, 2023
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2023 to Jul 31, 2026
    • Secondary endpoints: 6 to 20
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this project is to improve the clinical response and personal recovery of patients with treatment-resistant schizophrenia (TRS).
Trial Details
NCT Number NCT05337904
Lead Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions
(from sponsor)		 Treatment-resistant Schizophrenia, Deep Brain Stimulation
Related terms Schizophrenia, Schizophrenia, Treatment-Resistant
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov